Contracts Royal SunAlliance & Cambridge University
InterX PLC
10 March 2000
INTERX PLC
('InterX' or the 'Group')
Cromwell wins contracts
with
Royal SunAlliance and Cambridge University Press
InterX, which today announced full details of the merger with Cromwell
Media Limited ('Cromwell'), together with interim results for the 27
weeks ended 5 February 2000, is pleased to announce that Cromwell has
secured two significant contracts with Royal SunAlliance Insurance UK
('Royal SunAlliance') and Cambridge University Press.
The contract with Royal SunAlliance, part of one of the world's leading
international insurance companies and the largest underwriter of UK
general insurance risks, is for the provision of a UK-wide BladeRunner
licence, along with services to develop their online systems.
The contract with Cambridge University Press is to supply a BladeRunner
licence and services to build an online content delivery and e-commerce
platform. Cambridge University Press is the printing and publishing
house of the University of Cambridge. Founded in 1534, the world's
oldest press is today one of the largest educational and academic
publishers, producing more than 2,000 titles a year in print and
electronic form. Cambridge University Press is an international
publisher, drawing authors from more than 100 countries and distributing
its products to almost 200.
Jon Quigly, Business Systems Manager of Royal SunAlliance, commented:
'Royal SunAlliance Insurance UK has purchased a BladeRunner software
licence from Cromwell and are working together on Royal SunAlliance's UK
internet strategy as they bring together their UK direct operations.'
Dr Conrad Guettler, Journals Director of Cambridge University Press,
commented:
'Cambridge University Press has purchased the BladeRunner family of
products from Cromwell and are working together on developing the
Press's internet publishing platforms and strategy.'
Rob Bruce, Chief Executive of Cromwell, added:
'Cromwell is focusing initially on developing its target markets of
financial services and media/publishing. We are convinced our
technology provides organisations with a significant competitive
advantage and we are delighted to have won these strategic product sales
with such prestigious companies. These contracts demonstrate that
Cromwell can compete and win.'
James Wickes, Chief Executive of InterX, commented:
'When we announced our intention to merge with Cromwell, we knew that
its technology was world class. Using the Group's resources, we shall
now drive Cromwell's aggressive expansion.'
Enquiries:
InterX 020 7457 2020 (today)
020 8410 7200 (thereafter)
James Wickes, Chief Executive Email: jwickes@interx.co.uk
Simon Barker, Commercial Director Email: sbarker@interx.co.uk
Simon Miesegaes, Finance Director Email: smiesegaes@interx.co.uk
Charterhouse Securities 020 7248 4000
Colin La Fontaine Jackson, Director Email: clafj@charterhouse.co.uk
College Hill 020 7457 2020
Nicola Weiner Email: nicola@collegehill.com
Mary Matthewson Email: mary@collegehill.com
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.